Elisa Bertoli

Aviano, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

BRAF class II-III mutations in NSCLC: a single center experience.

BRAF class II-III mutations in NSCLC: a single center experience.

Journal: Frontiers in oncology

Published: October 02, 2025

Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor (EGFR) Common Mutations: New Strategies.

Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor (EGFR) Common Mutations: New Strategies.

Journal: Cancers

Published: February 11, 2025

Immunotherapy in Oncogene-Addicted NSCLC: Evidence and Therapeutic Approaches.

Immunotherapy in Oncogene-Addicted NSCLC: Evidence and Therapeutic Approaches.

Journal: International journal of molecular sciences

Published: December 20, 2024

EML4-ALK: Update on ALK Inhibitors.

EML4-ALK: Update on ALK Inhibitors.

Journal: International journal of molecular sciences

Published: December 04, 2024

Matters of the Heart: Cardiotoxicity Related to Target Therapy in Oncogene-Addicted Non-Small Cell Lung Cancer.

Matters of the Heart: Cardiotoxicity Related to Target Therapy in Oncogene-Addicted Non-Small Cell Lung Cancer.

Journal: International journal of molecular sciences

Published: November 22, 2024

Navigating Therapeutic Challenges in BRAF-Mutated NSCLC: Non-V600 Mutations, Immunotherapy, and Overcoming Resistance.

Navigating Therapeutic Challenges in BRAF-Mutated NSCLC: Non-V600 Mutations, Immunotherapy, and Overcoming Resistance.

Journal: International journal of molecular sciences

Published: October 31, 2024

Targeted Therapy in Mesotheliomas: Uphill All the Way.

Targeted Therapy in Mesotheliomas: Uphill All the Way.

Journal: Cancers

Published: April 06, 2024

Case report: First evidence of impressive efficacy of modulated dose selpercatinib in a young Caucasian with ANK3-RET fusion-positive NSCLC.

Case report: First evidence of impressive efficacy of modulated dose selpercatinib in a young Caucasian with ANK3-RET fusion-positive NSCLC.

Journal: Frontiers in oncology

Published: October 04, 2023

Estimating survival in patients with melanoma brain metastases: prognostic value of lactate dehydrogenase.

Estimating survival in patients with melanoma brain metastases: prognostic value of lactate dehydrogenase.

Journal: Melanoma research

Published: July 04, 2023

Therapeutical Options in ROS1-Rearranged Advanced Non Small Cell Lung Cancer.

Therapeutical Options in ROS1-Rearranged Advanced Non Small Cell Lung Cancer.

Journal: International journal of molecular sciences

Published: June 10, 2023

Liquid Biopsy in NSCLC: An Investigation with Multiple Clinical Implications.

Liquid Biopsy in NSCLC: An Investigation with Multiple Clinical Implications.

Journal: International journal of molecular sciences

Published: May 21, 2023

The SAFFO Study: Sex-Related Prognostic Role and Cut-Off Definition of Monocyte-to-Lymphocyte Ratio (MLR) in Metastatic Colorectal Cancer.

The SAFFO Study: Sex-Related Prognostic Role and Cut-Off Definition of Monocyte-to-Lymphocyte Ratio (MLR) in Metastatic Colorectal Cancer.

Journal: Cancers

Published: November 09, 2022

Showing 1-12 of 27

Last Updated: 09/26/2026